Pharmafile Logo
Pharmafocus logo
Advanced Search

IMS

Showing 15 posts of 15 posts found.

china_flag

Chinese government to lift drug price controls

May 5, 2015
Sales and Marketing China, Drug pricing, GSK, IMS, Xarelto, government

The Chinese government has announced that it will remove price caps for most medicines and allow the market to play …

News
Kadcyla image

Global drug spending set to top $1 trillion

November 20, 2014
Sales and Marketing Gilead, IMS, Kadcyla, Perjeta, drugs, hepatitis C, sovaldi, spend

Worldwide spending on drugs will reach over $1 trillion in 2014 and $1.3 trillion by 2018, according to a new …

News
cancer image

Global cancer drug spend slows

May 7, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, IMS, spending

Spending on cancer drugs worldwide is slowing, according to a new report from the IMS Institute for Healthcare Informatics. The …

News

Pharma must use cloud-based tech, says report

March 13, 2014
Medical Communications, Sales and Marketing IMS, cloud, digital, pharma, technology

Cloud-based technologies are the way forward for the pharma sector as global budget pressures continue to bite – that is …

News
Germany flag

German law could see pharma discounts published

February 18, 2014
Sales and Marketing AMNOG, Germany, IMS, NICE, prices

Pharma companies are apprehensive about German lawmakers opening Pandora’s Box this week if they go ahead with plans to publish …

News

J&J: we’re proud to top social media leaderboard

January 27, 2014
Medical Communications, Sales and Marketing IMS, J&J, JJ, Janssen, digital, epatient, pharma

Johnson & Johnson says recognising the rise of the ePatient and being willing to share its corporate plans with the …

News

J&J tops social media leaderboard

January 22, 2014
Medical Communications, Research and Development, Sales and Marketing Facebook, IMS, J&J, JJ, Twitter, You Tube, social media

A new report has found that Johnson & Johnson is the most engaged pharma company when it comes to using …

News
Prescriptions image

Global prescriptions cost to hit $1 trillion

November 20, 2013
Medical Communications, Research and Development, Sales and Marketing IMS, UK, prescriptions

The worldwide cost of medicine prescriptions will for the first time hit $1 trillion next year as drugs get more …

News
NICE image

NICE medicines uptake dissected

November 23, 2012
Sales and Marketing HSCIC, IMS, NICE

Lack of diagnosis, ignoring required tests, muddled commissioning and local policy variations are among the key reasons why NICE-approved drugs …

News

Huge increase in emerging market spending to lift pharma

July 16, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, IMS, emerging markets, pharmerging

The global pharmaceutical market is set to return to stronger growth of 5-7% by 2016, according to a new forecast. …

Feature

Generics push US drug growth to $307bn

April 20, 2011
IMS, IMS Health, drug spending, healthcare spending

Generics replaced branded drugs as the main growth drivers for the US pharmaceutical market in 2010. The market saw just …

News

Pharma sector growth to improve in 2011

November 19, 2010
Sales and Marketing 2011, IMS, IMS Health, forecast, growth, pharma

2011 should be a better year for pharma as emerging markets and recovering economies will help growth, say analysts at …

News

IMS promotes Adel Al-Saleh to senior sales role

July 26, 2010
Sales and Marketing IMS, appointment, sales and marketing

IMS Health has promoted Adel Al-Saleh to the newly created position of senior vice president, sales and global account management. …

Appointment

Emerging markets and generics poised to drive pharma growth

April 20, 2010
Sales and Marketing IMS, em, emerging markets

The global pharma market will reach $1.1 trillion in 2014 through growth primarily driven by emerging markets and generics, according …

News

IMS adds countries to ‘pharmerging’ hit-list

March 18, 2010
Sales and Marketing China, IMS, em

IMS Health has added 10 more countries to its list of ‘pharmerging markets’ which represent the future of pharma industry …

News

Latest content

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024